Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Drapkin Kimberlee C Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Drapkin Kimberlee C (Director) has filed a Form 4 on KINETA, INC./DE
Txns: Granted 20,000 options to buy @ $2.58, valued at $51.6k
06/07/2023 4 Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2023 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 6,315 shares @ $1.1, valued at $6.9k
Sold 7,781 shares @ $1.12, valued at $8.7k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $4.01, valued at $200.5k
02/03/2022 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 27,500 shares @ $0
Granted 55,000 options to buy @ $7.56, valued at $415.8k
01/11/2022 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 4,595 shares @ $7.3, valued at $33.5k
Sold 8,222 shares @ $6.65, valued at $54.7k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/22/2021 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 16,201 shares @ $12.03, valued at $194.9k
Sold 10,000 shares @ $10.03, valued at $100.3k
Sold 3,799 shares @ $12, valued at $45.6k
Exercised 3,016 options to buy @ $0.48, valued at $1.4k
Exercised 6,775 options to buy @ $0.74, valued at $5k
Exercised 3,710 options to buy @ $2.36, valued at $8.8k
Exercised 3,799 options to buy @ $2.36, valued at $9k
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2020 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 7,200 shares @ $8.06, valued at $58k
08/18/2020 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 984 shares @ $4.64, valued at $4.6k
Sold 454 shares @ $4.86, valued at $2.2k
Sold 744 shares @ $4.71, valued at $3.5k
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2020 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 2,624 shares @ $7.78, valued at $20.4k
08/16/2019 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 670 shares @ $4.1, valued at $2.7k
Sold 648 shares @ $4, valued at $2.6k
Sold 1,018 shares @ $3.92, valued at $4k
02/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/28/2018 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Exercised 12,700 options to buy @ $2.36, valued at $30k
08/15/2018 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 14,400 shares @ $0
03/12/2018 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 5,267 shares @ $25.01, valued at $131.7k
Exercised 3,759 options to buy @ $0.48, valued at $1.8k
03/07/2018 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 4,000 shares @ $21.21, valued at $84.8k
Sold 1,267 shares @ $22.07, valued at $28k
02/05/2018 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 97,500 options to buy @ $23.98, valued at $2.3M
07/01/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
03/19/2009 4 Drapkin Kimberlee C (CFO) has filed a Form 4 on EPIX Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy